---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-093224"
form_type: "8-K"
ticker: "DMII"
cik: "0002040475"
company_name: "Drugs Made In America Acquisition II Corp."
filed_at: "2025-09-29T23:59:59+00:00"
generated_at: "2026-05-17T05:28:19.174248+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# SPAC Drugs Made In America Acquisition II Corp. closes $500M IPO; $500M in trust

## Summary
- Priced and closed IPO of 50M units at $10/unit for gross proceeds of $500M.
- Concurrent private placement of 1.2M units ($12M) to sponsor and Cantor Fitzgerald.
- Net proceeds of $500M deposited into trust account for public shareholders.
- Units trade on Nasdaq under DMIIU; ordinary shares and rights to trade separately later.
- Appointed Catherine Do, G. Sridhar Prasad, Myron W. Shulgan to board and committees.

## SEC filing metadata
- accession: 0001213900-25-093224
- form_type: 8-K
- ticker: DMII
- cik: 0002040475
- company_name: Drugs Made In America Acquisition II Corp.
- filed_at: 2025-09-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/0001213900-25-093224-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea0258969-8k_drugs2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-093224
- JSON: https://secwatch.observer/filing/0001213900-25-093224.json
- Plain text: https://secwatch.observer/filing/0001213900-25-093224.txt

## Key facts
- Equity Issuances
  Drugs Made In America Acquisition II Corp. issued 1,200,000 units of unit to the Sponsor and Cantor for $10.00 per Private Unit, generating total proceeds of $12,000,000.
  - Security: unit
  - Shares: 1,200,000 units
  - Purchaser: the Sponsor and Cantor
  - Consideration: $10.00 per Private Unit, generating total proceeds of $12,000,000
  source text: Simultaneously with the closing of the IPO, the Company consummated the private placement ("Private Placement") of an aggregate of 1,200,000 units (the "Private Units") to the Sponsor and Cantor, with 700,000 Private Units to the Sponsor and 500,000 Private Units to Cantor, at a price of $10.00 per Private Unit, generating total proceeds of $12,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/0001213900-25-093224-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.